Strategic electrochemical oxidation of vinblastin sulfate (an anticancer drug) via PVP-functionalized strontium oxide

Sana-Ul-Nisa Lanjar1, Amber R Solangi1, Nahjul Batool2

  • 1National Centre of Excellence in Analytical Chemistry, University of Sindh Jamshoro 76080 Pakistan amber.solangi@usindh.edu.pk.

RSC Advances
|October 3, 2024
PubMed

Insights

Researchers developed polyvinylpyrrolidone functionalized strontium oxide nanoparticles (PVP-SrO NPs) as a novel sensor. This sensor accurately detects the anticancer drug vinblastine sulfate (VNB) in human blood serum.

Area of Science:

  • Nanotechnology and Materials Science
  • Analytical Chemistry
  • Biomedical Engineering

Background:

  • Cancer is a leading cause of death globally, increasing the demand for effective chemotherapeutic treatments.
  • The toxicity of cytotoxic agents necessitates reliable analytical methods for drug monitoring in patients.
  • Developing sensitive and cost-effective sensors is crucial for therapeutic drug monitoring.

Purpose of the Study:

  • To synthesize and characterize polyvinylpyrrolidone functionalized strontium oxide nanoparticles (PVP-SrO NPs).
  • To utilize PVP-SrO NPs as a sensor for the sensitive detection of vinblastine sulfate (VNB).
  • To evaluate the sensor's performance in detecting VNB in human blood serum samples.

Main Methods:

  • Synthesis of PVP-SrO NPs using a simple and straightforward method.
  • Characterization of NPs using Fourier transform infrared spectroscopy (FTIR), X-ray diffraction spectroscopy (XRD), scanning electron microscopy (SEM), and energy dispersive spectroscopy (EDS).
  • Electrochemical analysis using electrochemical impedance spectroscopy and cyclic voltammetry to assess sensor conductivity and VNB detection capabilities.

Main Results:

  • Successful synthesis and characterization of PVP-SrO NPs with confirmed functionality, crystalline nature, and nanobead morphology.
  • The PVP-SrO/GCE sensor demonstrated enhanced conductivity compared to bare GCE.
  • The sensor exhibited a wide linear dynamic range (0.05–60 μM) for VNB detection with a low limit of detection (LOD) of 0.005 μM.
  • High percent recovery (96–103%) confirmed the sensor's accuracy in detecting VNB in human blood serum.

Conclusions:

  • The fabricated PVP-SrO NPs sensor offers a sensitive, selective, and cost-effective method for detecting vinblastine sulfate.
  • The sensor's performance, including processing simplicity and enhanced efficacy, surpasses previously reported sensors.
  • This novel sensor holds significant potential for therapeutic drug monitoring in clinical settings.